Galen Estrogen Ring Will Be Marketed By Warner Chilcott 260-Rep Force
Executive Summary
Galen's acquisition of Warner Chilcott will provide the Irish company with a 260-rep sales force for the U.S. launch of its intravaginal estrogen ring product expected in 2001.
You may also be interested in...
Galen HRT Ring Femring Will Be Approved By February Or March, CEO Predicts
Galen's estradiol ring product Femring will be approved by FDA in February or March, CEO Roger Boissonneault said in an earnings call Feb. 11
Galen HRT Ring Femring Will Be Approved By February Or March, CEO Predicts
Galen's estradiol ring product Femring will be approved by FDA in February or March, CEO Roger Boissonneault said in an earnings call Feb. 11
Lilly Sells Sarafem: Galen Adds Drug To Women’s Health Line For $295 Mil.
Galen is adding Sarafem to its line of women's health products through a $295 mil. deal with Lilly